Exchange: NASDAQ·Updated 10:48 AM EDT
PMN logo

PMN ProMIS Neurosciences

$12.55
$0.35
(2.71%)
Today
Reported EarningsAug 13
Mkt Cap$115.68M
Vol5,501.00

About PMN

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.
36

Bearish Sentiment

How do you feel about PMN?

Advertisement|Remove ads.